PTGER4 and kidney disorder: In the mouse and rat models of diabetic and non-diabetic kidney disease studied and with the particular small molecule (ONO-AE3-208) administered for the dose and duration described, EP4 inhibition consistently resulted in a preservation of glomerular permselectivity and a prevention of renal injury.